Physician

Stephen Paul Dubin, MD

According to 2025 Medicare claims, Stephen Dubin, MD (NPI: 1023311040) practices general practice in the Las Vegas-Henderson-North Las Vegas, NV market, with the plurality of this provider's patient population coming from Clark, NV. This provider's primary affiliated billing organization is DUBIN MEDICAL CONSULTANTS INC (NPI: 1982274981) and primary practice location at 89129-7529.

Dubin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 403 traditional Medicare patients, billed 21,967 HCPCS/CPT codes, and received $17,862,370 in Medicare payments. The top billing code was 15271 (Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less). Part D data shows 563 prescription claims across 89 beneficiaries totaling $51,391 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 11 claims. Open Payments data shows 1 records totaling $140. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $259,943 to $17,862,370. In contrast, Part D prescription costs have fallen sharply in recent years, from $323,792 to $51,391. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $5,539 and ending at $5,698.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	627	3,324	$259,943
2016	436	2,272	$188,272
2017	676	3,859	$306,455
2018	508	3,366	$262,577
2019	653	3,356	$256,529
2020	708	4,594	$336,346
2021	404	2,802	$377,474
2022	435	22,775	$10,687,080
2023	602	43,058	$33,558,579
2024	403	21,967	$17,862,370

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	265	6,362	$323,792
2016	270	6,312	$367,148
2017	260	6,914	$383,340
2018	296	8,266	$473,782
2019	329	8,918	$451,205
2020	347	8,400	$428,930
2021	396	6,063	$346,858
2022	397	3,306	$257,278
2023	308	1,830	$138,083
2024	89	563	$51,391

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	18	82	$2,199
2016	30	186	$5,532
2017	35	232	$8,656
2018	18	256	$10,033
2019	42	210	$3,550
2020	17	174	$3,326
2021	N/R	115	$2,769
2022	N/R	39	$1,662
2023	85	180	$1,054,183
2024	N/R	11	$494

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
15271	Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less	118	508	$111
G0181	Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow	213	934	$79
99348	Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes	164	1,507	$58
G0180	Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and	103	111	$40
G0179	Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a	161	375	$32

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	12	420	$6,395
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	367	$414
Oxycodone Hcl	Oxycodone Hcl	11	330	$324
Alprazolam	Alprazolam	49	1,687	$179
Levothyroxine Sodium	Levothyroxine Sodium	15	1,170	$150

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0442	Stationary oxygen contents, liquid, 1 month's supply = 1 unit	N	N/R	11	$494

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$140	ABIOMED
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Stephen Paul Dubin, MD?

Tedicare shows public-source Medicare data for Stephen Paul Dubin, MD (NPI 1023311040), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Stephen Paul Dubin, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Stephen Paul Dubin, MD?

Stephen Paul Dubin, MD is linked to DUBIN MEDICAL CONSULTANTS INC (billing NPI 1982274981) in the available physician profile data.

Does Stephen Paul Dubin, MD have Open Payments data?

Stephen Paul Dubin, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.